$CRVS stock has now risen 10% today, according to our price data from Polygon. There has been approximately $4,562,820 of trading volume.
Here is what we see in our data on $CRVS (you can track the company live on Quiver's $CRVS stock page):$CRVS Insider Trading Activity
$CRVS insiders have traded $CRVS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CRVS stock by insiders over the last 6 months:
- ADVISORS LLC ORBIMED sold 1,176,332 shares for an estimated $4,891,894
- PETER A. THOMPSON sold 1,176,332 shares for an estimated $4,891,894
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CRVS Hedge Fund Activity
We have seen 64 institutional investors add shares of $CRVS stock to their portfolio, and 47 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. added 4,254,742 shares (+152.6%) to their portfolio in Q2 2025, for an estimated $17,018,968
- SAMLYN CAPITAL, LLC removed 4,065,935 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $16,263,740
- BLACKROCK, INC. added 3,181,392 shares (+301.0%) to their portfolio in Q2 2025, for an estimated $12,725,568
- MILLENNIUM MANAGEMENT LLC removed 1,637,138 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $6,548,552
- PERCEPTIVE ADVISORS LLC added 1,438,595 shares (+inf%) to their portfolio in Q2 2025, for an estimated $5,754,380
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) removed 1,000,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $3,180,000
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 883,527 shares (-92.9%) from their portfolio in Q2 2025, for an estimated $3,534,108
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CRVS Analyst Ratings
Wall Street analysts have issued reports on $CRVS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 05/20/2025
- Oppenheimer issued a "Outperform" rating on 05/09/2025
To track analyst ratings and price targets for $CRVS, check out Quiver Quantitative's $CRVS forecast page.
$CRVS Price Targets
Multiple analysts have issued price targets for $CRVS recently. We have seen 2 analysts offer price targets for $CRVS in the last 6 months, with a median target of $14.0.
Here are some recent targets:
- Graig Suvannavejh from Mizuho set a target price of $11.0 on 05/20/2025
- Jeff Jones from Oppenheimer set a target price of $17.0 on 05/09/2025
You can track data on $CRVS on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
